Evidence map›Paper›PMID 39509409›Full record

ArticlePloS one2024

A protocol for modeling the factors influencing the deployment of the COVID-19 vaccine across African countries.

Obidimma Ezezika, Tiana Stephanie Kotsaftis, Edina Amponsah-Dacosta, Suleyman Demi, Eric Omori Omwenga, Samuel Mong'are, Trust Zaranyika, Oluwaseun Ariyo, Kandala Ngianga-Bakwin, Edward Kwabena Ameyaw

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Obidimma EzezikaFaculty of Health Sciences, Global Health & Innovation Lab, School of Health Studies, University of Western Ontario, London, Canada.ORCID 0000-0001-7832-0483
Tiana Stephanie KotsaftisFaculty of Health Sciences, Global Health & Innovation Lab, School of Health Studies, University of Western Ontario, London, Canada.
Edina Amponsah-DacostaFaculty of Health Sciences, Vaccines for Africa Initiative, School of Public Health, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-3913-0457
Suleyman DemiSchool of Social Work, Algoma University, Sault Ste Marie, Canada.
Eric Omori OmwengaDepartment of Medical Microbiology and Parasitology, School of Health Sciences, Kisii University, Kisii, Kenya.
Samuel Mong'areDepartment of Medical Microbiology and Parasitology, School of Health Sciences, Kisii University, Kisii, Kenya.
Trust ZaranyikaDepartment of Internal Medicine, University of Zimbabwe, Harare, Zimbabwe.
Oluwaseun AriyoDepartment of Human Nutrition and Dietetics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Kandala Ngianga-BakwinDepartment of Epidemiology and Biostatistics, Schulich School of Medicine and Surgery, University of Western Ontario, London, Canada.
Edward Kwabena AmeyawInstitute of Policy Studies and School of Graduate Studies, Lingnan University, Tuen Mun, Hong Kong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence fails to capture disparities amongst African countries in terms of the measure of administered COVID-19 vaccine doses per 100 people. Assessment of data on doses secured, administered, and supplied was undertaken to investigate quantitative measures that impacted COVID-19 vaccine deployment, thereby emphasizing distribution and supply indicators. We employ a full linear regression to identify independent variables that have an impact on vaccination rates, including macroeconomic indicators such as World Bank Income Classification, Gross Domestic Product (GDP) per capita and various indices such as Health Access and Quality Index, Human Development Index, Global Peace Index, Education Index, Political Stability Index and Government Effectiveness. This analysis aims to construct a statistical model utilizing regression analysis to identify key drivers of COVID-19 vaccine deployment in Africa and offer insights into vaccination disparities in the continent. Recognizing the global importance of achieving high vaccination rates, the study sheds light on specific challenges faced by individual countries within Africa, thereby emphasizing the need for tailored efforts. Beyond COVID-19, the research contributes to understanding the relationship between vaccination rates and social indicators that, potentially impact broader public health concerns and global vaccination programs. This study provides a foundation for informed policymaking to enhance vaccine accessibility, inform targeted programs, and improve individual health systems, thereby addressing broader implications for global health.

Indexed as

COVID-19COVID-19 VaccinesAfricaHumansImmunization ProgramsSARS-CoV-2VaccinationCOVID-19 Vaccines

Identifiers

PMID39509409
PMCPMC11542824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.